DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Sundram Fasteners Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 52 min ago·5 Oct 2026, 8:52 am

Sundram Fasteners

Sundram Fasteners Limited has submitted a compliance certificate to the stock exchanges. This document confirms that the company has fulfilled its regulatory obligations under the SEBI (Depositories and Participants) Regulations, 2018. The filing is a routine administrative requirement designed to ensure transparency and adherence to market norms.

For investors, this news is largely procedural. It signals that the company is up to date with its reporting duties and maintains a clean compliance record. While it does not directly impact the company's financial performance or business operations, it reinforces investor confidence in the firm's governance standards.

Moving forward, market participants should focus on the company's operational updates and quarterly results. This regulatory filing is a standard administrative step and does not alter the company's strategic outlook or stock price trajectory.